A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection

Virology

Volumn 281, Issue 2, 2001, Pages 205-215

  Flodström, Malin ^a   Horwitz, Marc S ^a   Maday, Amy ^a   Balakrishna, Deepika ^a   Rodriguez, Enrique ^a   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Coxsackievirus; Hepatitis; Insulin; Insulin dependent diabetes mellitus; Nitric oxide; Nitric oxide synthase; NOS2; Pancreatic cell; Pancreatitis

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B4; COXSACKIE VIRUS INFECTION; DISEASE ASSOCIATION; HISTOPATHOLOGY; HYPERGLYCEMIA; HYPOGLYCEMIA; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SURVIVAL; VIRUS HEPATITIS;

COXSACKIEVIRUS;

EID: 0035866623     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0801     Document Type: Article

References (57)

1. Free radicals in viral pathogenesis: Molecular mechanisms involving superoxide and NO
2. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity
3. Genetics of coxsackievirus virulence
4. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury
5. The harmony of the spheres: Inducible nitric oxide synthase and related genes in pancreatic beta cells
6. The inducible form of nitric oxide synthase (iNOS) in insulin-producing cells
7. Expression and expressional control of nitric oxide synthases in various cell types
8. 2+response to glucose in mouse beta-cells infected with coxsackie B or Echo virus
9. Murine natural killer cells limit coxsackievirus B3 replication
10. The role of enteroviral infections in the development of IDDM: Limitations of current approaches
11. Nitric oxide: Pathophysiological mechanisms
12. Double-stranded RNA inhibits b-cell function and induces islet damage by stimulating b-cell production of nitric oxide
13. Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry
14. Protection from lethal coxsackievirus-induced pancreatis by expression of gamma interferon
15. Enterovirus infections and insulin dependent diabetes mellitus - Evidence for causality
16. Rapid interferon-g-dependent clearance of influenza virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice
17. Inhibition of viral replication by interferon-g-induced nitric oxide synthase
18. Nitric oxide in interstitial nephritis and other autoimmune diseases
19. Environmental factors in the pathogenesis of type 1 diabetes mellitus
20. Nitric oxide in autoimmune disease: Cytotoxic or regulatory mediator?
21. Nitric oxide: Cytotoxicity versus cytoprotection - How, why, when, and where?
22. Pathological changes in the pancreas of mice following infection with coxsackie B viruses
23. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice
24. Coxsackievirus B4 infection in animals with diabetes mellitus genotype
25. Nitric oxide and macrophage function
26. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase
27. Enteroviruses: Polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses
28. The role of B lymphocytes in coxsackievirus B3 infection
29. Role of oxidants in microbial pathophysiology
30. XIV. International Union of Pharmacology nomenclature in nitric oxide research
31. Biological effects of aminoguanidine: An update
32. Hepatitis associated with a coxsackie B5 virus infection during late pregnancy
33. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration
34. Nitric oxide inhibits the HIV-1 response transcriptase activity
35. Impaired liver regeneration in inducible nitric oxide synthase deficient mice
36. Coxsackieviruses and pancreatitis
37. Severity of disease induced by a pancreatropic Coxsaekie B4 virus correlates with the H-2Kq locus of the major histocompatibility complex
38. Coxsackieviruses and diabetes
39. T cells contribute to disease severity during coxsackievirus B4 infection
40. Does nitric oxide play a critical role in viral infections?
41. Mechanisms of coxsackievirus-induced damage to human pancreatic b-cells
42. Picornaviruses and their replication
43. An antiviral mechanism of nitric oxide: Inhibition of a viral protease
44. Pathogenesis of virus-induced diabetes in mice
45. Mammalian nitric oxide synthases
46. In vivo infection of mice with Coxsackie B4 virus induces long-term functional changes in pancreatic islets with minimal alteration in blood glucose
47. Coxsackie B4 virus induces short-term changes in the metabolic functions of mouse pancreatic islets in vitro
48. Diabetes mellitus due to viruses - Some recent developments
49. Coxsackie B4 viruses with the potential to damage beta cells of the islets are present in clinical isolates
50. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells
51. Virus-induced diabetes mellitus. Glucose abnormalities produced in mice by the six members of the Coxsackie B virus group
52. Coxsackievirus B4 infection of the mouse pancreas: The role of natural killer cells in the control of virus replication and resistance to infection
53. Susceptibility of mice to group B coxsackie virus is influenced by the diabetic gene
54. Chemical biology of nitric oxide, insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide
55. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis
56. Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B4
57. Inducible nitric oxide synthase protection against coxsackievirus pancreatitis